ADAPTIR
Live / Registered — Registered (as of 16 May 2023)
What this means for you
Registered since 16 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86974244
- Registration number
- 7055489
- Mark type
- Stylized text
- Filed
- 13 Apr 2016
- Published for opposition
- 07 Mar 2017
- Registered
- 16 May 2023
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 040 — Treatment of materials: Production, namely, custom manufacturing for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of cancer and autoimmune disorders and conditions
- Class 042 — Scientific and technological services: Product commercialization in the nature of pharmaceutical product evaluation and product development for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of cancer and autoimmune disorders and conditions
Owner
- APTEVO RESEARCH AND DEVELOPMENT LLC, SEATTLE, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, SEATTLE, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, SEATTLE, WA, US
- Emergent Product Development Seattle, LLC, Seattle, WA, US
Prosecution history
- 16 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Mar 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 04 May 2020 — USE AMENDMENT FILED
- 02 Oct 2020 — NOTICE OF REINSTATEMENT E-MAILED
- 01 Oct 2020 — REINSTATEMENT GRANTED - SOU FILED
- 01 Oct 2020 — ASSIGNED TO PETITION STAFF
- 02 Jul 2020 — TEAS REQUEST FOR REINSTATEMENT
- 08 Jun 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Jun 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Jun 2020 — PAPER RECEIVED
- 07 Nov 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2019 — SOU EXTENSION 5 GRANTED